Life Sciences

Modernizing life science manufacturing

Issue link: https://read.uberflip.com/i/1182518

Contents of this Issue

Navigation

Page 2 of 5

SHARE: Modernizing Life Science Manufacturing: How analytics, IoT and the cloud are rewriting drug production 3 need a partner, such as AWS, that has tailored its cloud offering to the pressures and requirements of good manufacturing practice (GMP) environments. THE VALUE OF AUTOMATED AND CONTINUOUS COMPLIANCE IN THE CLOUD Manu f a c tu re rs t hat r u n t he i r re g u l ate d G x P workloads on the AWS Cloud are realizing a range of unique benefits, including enhanced traceability and trackability of what's occurring in their IT environment, near real-time testing and enhanced speed of setup. The pharmaceutical company Merck is one of many companies that run regulated workloads on the AWS Cloud, benefiting from the automated and continuous compliance this provides. Utilizing AWS CloudTrail, Merck has the capability to log every change to its system, enabling it to provide auditors with details of all revisions. Similarly, AWS Config is used to show auditors how its environment was configured on any day in the past, improving on the point-in- time approach to compliance that was common in the industry 1 . Similarly, Moderna Therapeutics runs day-to-day drug manufacturing GxP workloads in the AWS Cloud to maximize cost savings and agility. From Moderna's inception in 2010, the company embraced a cloud-first strategy 2 . Traditionally, a biotech would establish an on-premises infrastructure when it needed to run regulated workloads. Moderna believed running GxP workloads using SAP on the AWS Cloud could be done more quickly and at less cost than setting up on-premise hardware. That belief has been validated by Moderna's ability to construct a 200,000-square- 1 AWS re:Invent 2016: Continuous Compliance in the AWS Cloud (LFS302). (2016). 2 Damiani, M. & Johnson, D. Moderna Therapeutics Case Study – Amazon Web Services (AWS). Amazon Web Services, Inc. Available at: https://aws. amazon.com/solutions/case-studies/moderna-therapeutics/. (Accessed: 7th August 2018) foot GMP facility whose supply chain and processes are driven by a GxP cloud IT environment. The AWS Cloud-based system enables a fully integrated ecosystem of applications. "For us, it doesn't make sense to see any company going into the old way of doing things, with the agility, flexibility and the integration that you can bring using AWS and SAP," Marcello Damiani, Chief Digital Officer at Moderna, said. "It's been flexible enough to allow us to build in a very fast fashion 3 ." Companies including Merck and Moderna are using the cloud to enable a new level of manufacturing agility and compliance to enhance their operational performance. By working with industry members and regulatory consultancy Lachman Consultant Services, AWS created a white paper to outline how the AWS Cloud platform can be used in a manner that is consistent with GxP compliance guidelines, creating valuable information to guide companies interested in adopting the cloud for regulated life science workloads. UNLOCKING THE VALUE OF EXISTING MANUFACTURING DATA WITH ANALYTICS AND MACHINE LEARNING Seeing an opportunity to significantly lower costs while increasing output reliability and quality, some manufacturers are integrating data analytics into existing production environments to gain insights into process parameters that determine critical quality metrics, enabling them to identify and resolve issues faster. The capability to glean fresh insights from existing data is made possible by the ability for manufacturers to store and analyze vast amounts of information in an efficient manner in the AWS Cloud. 3 [Whitepaper] AWS and SAP: How and Why Companies Run Regulated Workloads in the Cloud. Available at: https://pages.questexweb.com/ AWSandSAP-December2017-Registration.html?source=meta. (Accessed: 29th June 2018)

Articles in this issue

Links on this page

view archives of Life Sciences - Modernizing life science manufacturing